IPP Bureau
Zymo invests in Star Array to develop superfast PCR platform
By IPP Bureau - April 27, 2022
Star Array's focus has been on the development of an automated (cassette-based) nucleic acid purification system coupled with its superfast nucleic acid amplification technology
Remilk to build the world's largest precision fermentation facility
By IPP Bureau - April 27, 2022
Food-tech disruptor prepares to vastly scale dairy-identical, non-animal milk protein production in a pioneering sustainable industrial park in Denmark
Takeda awarded for Supply Chain and Pharma 4 at ISPE awards
By IPP Bureau - April 27, 2022
Recognition illustrates Takeda’s patient-centricity throughout its manufacturing and supply processes
Lupin appoints Diana Amador-Toro as Senior Vice President, Global Compliance
By IPP Bureau - April 27, 2022
Diana is a senior leader with more than 38 years of field experience in U.S. FDA’s Office of Regulatory Affairs (ORA)
SPARSH Hospital introduces high precision Surgical Imaging and Navigation system
By IPP Bureau - April 27, 2022
The StealthStation S8 and O-arm Surgical Navigation solution make a complex surgery seem more routine and free of any errors
Tislelizumab plus chemo show promising results for esophageal cancer in Phase III study
By IPP Bureau - April 27, 2022
Results support the development of tislelizumab in potentially synergistic combinations across Novartis advanced therapeutic platforms for the treatment of an array of solid tumours
Syngene full-year revenue from operations up 19% to Rs. 2604 crore
By IPP Bureau - April 27, 2022
Revenue from operations up 15% to Rs. 758 crore in fourth quarter
Dr Mandaviya calls for innovation in the pharma and medical devices
By IPP Bureau - April 26, 2022
The minister was speaking at the 7th International conference on Pharma and Medical Devices sector; chairs two roundtable conferences with the CEOs
Malaysia awards three-year contract for Biocon Biologics’ Insugen
By IPP Bureau - April 26, 2022
Biocon Biologics’ Insugen formulations will be available to patients at all Ministry of Health hospitals, district health offices and health clinics
USFDA approves first Covid-19 treatment for young children
By IPP Bureau - April 26, 2022
This action makes Veklury the first approved Covid-19 treatment for children less than 12 years of age
Pharming gets positive review from UK MHRA for leniolisib
By IPP Bureau - April 26, 2022
A Promising Innovative Medicine (PIM) designation is an early indication that leniolisib is a candidate for the MHRA's Early Access to Medicines Scheme
Biocytogen signs RenMab/RenLite licensing agreement with BeiGene
By IPP Bureau - April 26, 2022
In addition, common light chain antibodies generated by RenLite mice can greatly improve the efficiency of downstream assembly of complex drug molecules such as bispecific antibodies and bispecific antibody-drug conjugates (bsADCs)
Lonza and Integral Molecular partner on biotherapeutics
By IPP Bureau - April 26, 2022
The respective expertise of Lonza and Integral Molecular will benefit drug developers in the assessment of the risk for off-target binding and activation
USFDA clears Franklin Mountain Medical's new dual catheter
By IPP Bureau - April 26, 2022
It enables precise visualization and treatment access to the left heart
Roche and Fitterfly co-create 90-day diabetes programme
By IPP Bureau - April 26, 2022
Designed to give instant insights on blood sugar, in-depth nutrition and wellness, this programme provides fitness assessments, personalisation and reports for doctors
